BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34625644)

  • 21. Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis.
    Wang Y; Jiang F; Xia R; Li M; Yao C; Li Y; Li H; Zhao Q; Shi M; Yu Y; Shao YW; Zhou G; Xia H; Miao L; Cai H
    Front Oncol; 2021; 11():701171. PubMed ID: 34671549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique genomic alterations of cerebrospinal fluid cell-free DNA are critical for targeted therapy of non-small cell lung cancer with leptomeningeal metastasis.
    Wang Y; Jiang F; Zhang Y; Li M; Li Y; Li H; Zhao Q; Shi M; Yu Y; Shao YW; Cai H; Miao L; Xia H
    Genomics; 2021 Nov; ():. PubMed ID: 34793951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing of cerebrospinal fluid in non-small-cell lung cancer patients with leptomeningeal metastasis: A systematic review.
    Gao T; Chen F; Li M
    Cancer Med; 2023 Feb; 12(3):2248-2261. PubMed ID: 36000927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma.
    Pan Z; Yang G; He H; Gao P; Jiang T; Chen Y; Zhao G
    Front Oncol; 2020; 10():387. PubMed ID: 32328453
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
    Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
    Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
    Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
    Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Metabolomic and Proteomic Profiles of Cerebrospinal Fluid in Ventricular and Lumbar Compartments in Relation to Leptomeningeal Metastases.
    Kwon JW; Im JH; Lee KY; Yoo BC; Lee JH; Kim KH; Kim JH; Shin SH; Yoo H; Gwak HS
    Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer.
    Nevel KS; DiStefano N; Lin X; Skakodub A; Ogilvie SQ; Reiner AS; Pentsova E; Boire A
    Neuro Oncol; 2020 May; 22(5):675-683. PubMed ID: 32352148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.
    Masuda T; Hattori N; Hamada A; Iwamoto H; Ohshimo S; Kanehara M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1465-9. PubMed ID: 21274533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay.
    Wooster M; McGuinness JE; Fenn KM; Singh VM; Franks LE; Lee S; Cieremans D; Lassman AB; Hershman DL; Crew KD; Accordino MK; Trivedi MS; Iwamoto F; Welch MR; Haggiagi A; Schultz RD; Huynh L; Sales E; Fisher D; Mayer JA; Kreisl T; Kalinsky K
    Clin Breast Cancer; 2022 Jun; 22(4):e457-e462. PubMed ID: 34920954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer.
    Liu Y; Liang Y; Li Q; Li Q
    Comput Struct Biotechnol J; 2023; 21():4238-4251. PubMed ID: 37692082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis.
    Li N; Liu Y; Duan J; Yang B; Bai H; Sun R; Yu L; Wang J
    Thorac Cancer; 2019 Aug; 10(8):1673-1682. PubMed ID: 31368671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic Profiles.
    Im JH; Yoo BC; Lee JH; Lee KY; Kim KH; Kim JH; Park HJ; Park M; Lee SH; Kwon JW; Shin SH; Yoo H; Yang J; Choi SA; Kim SK; Gwak HS
    Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of Clinicopathological Feature and Prognosis for 
Leptomeningeal Metastasis in Non-small Cell Lung Cancer].
    Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer.
    Ma C; Lv Y; Jiang R; Li J; Wang B; Sun L
    Oncol Lett; 2016 Jan; 11(1):619-623. PubMed ID: 26870256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy.
    Xu Y; Hu M; Zhang M; Zhong W; Yin X; Sun Y; Chen M; Zhao J; Si X; Wang H; Zhang X; Zhang L; Li J; Guan H; Yang Z; Wang M
    Lung Cancer; 2018 Nov; 125():142-149. PubMed ID: 30429013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
    Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
    Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment response to intrathecal chemotherapy with pemetrexed via an Ommaya reservoir in EGFR-mutated leptomeningeal metastases from non-small cell lung cancer: a case report.
    Li H; Lin Y; Yu T; Xie Y; Feng J; Huang M; Guo A; Liu X; Yin Z
    Ann Palliat Med; 2020 Jul; 9(4):2341-2346. PubMed ID: 32648459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep Learning-Based Classification of Cancer Cell in Leptomeningeal Metastasis on Cytomorphologic Features of Cerebrospinal Fluid.
    Yu W; Liu Y; Zhao Y; Huang H; Liu J; Yao X; Li J; Xie Z; Jiang L; Wu H; Cao X; Zhou J; Guo Y; Li G; Ren MX; Quan Y; Mu T; Izquierdo GA; Zhang G; Zhao R; Zhao D; Yan J; Zhang H; Lv J; Yao Q; Duan Y; Zhou H; Liu T; He Y; Bian T; Dai W; Huai J; Wang X; He Q; Gao Y; Ren W; Niu G; Zhao G
    Front Oncol; 2022; 12():821594. PubMed ID: 35273914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.